Anti-Cancer Drugs Journal Issues Research Articles in October 2021 Edition
September 20, 2021
September 20, 2021
LONDON, England, Sept. 20 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles, including the following topics, in its October 2021 edition:
Preclinical Reports:
* Vandetanib-eluting radiopaque beads for chemoembolization: physicochemi . . .
Preclinical Reports:
* Vandetanib-eluting radiopaque beads for chemoembolization: physicochemi . . .
